Access to Medicine Index+Access to Medicine Overall Score
2

Access to Medicine Overall Score

How did the company score in the Access to Medicine Index?
Company
Industry
Project
search
Year
Answer
Filtered answers
18 Known
+ 5 Unknown
= 23 Total results
Companies Values
GlaxoSmithKline+image
GlaxoSmithKline
United Kingdom
3.3
0-5 2014
Novo Nordisk+image
Novo Nordisk
Denmark
3
0-5 2014
Merck KGaA+image
Merck KGaA
2.8
0-5 2014
Johnson&Johnson+image
Johnson&Johnson
New Jersey (United States)
2.8
0-5 2014
Gilead Sciences+image
Gilead Sciences
California (United States)
2.8
0-5 2014
Novartis+image
Novartis
Switzerland
2.8
0-5 2014
AbbVie Inc.+image
AbbVie Inc.
Illinois (United States)
2.6
0-5 2014
Sanofi+image
Sanofi
France
2.6
0-5 2014
Merck & Co+image
Merck & Co
New Jersey (United States)
2.6
0-5 2014
Bayer AG+image
Bayer AG
Germany
2.5
0-5 2014
Eisai+image
Eisai
2.5
0-5 2014
Roche Holding+image
Roche Holding
Switzerland
2.3
0-5 2014
Pfizer+image
Pfizer
New York (United States)
1.9
0-5 2014
AstraZeneca+image
AstraZeneca
Sweden
1.9
0-5 2014
Eli Lilly & Co+image
Eli Lilly & Co
Indiana (United States)
1.7
0-5 2014
Astellas Pharma+image
Astellas Pharma
United Kingdom
1.6
0-5 2014
Daiichi Sankyo+image
Daiichi Sankyo
1.5
0-5 2014
Takeda Pharmaceutical+image
Takeda Pharmaceutical
1.5
0-5 2014
Alpina Foods+Image
Alpina Foods
Colombia
Unknown
0-5 2015
Grupo Sura+Image
Grupo Sura
Unknown
0-5 2014

Export: csv / json

Metric Type
Researched
Designed By
Topics
Research Policy
Designer Assessed
Report Type
Value Type
Number
Unit:
Range:
0-5

About

The Access to Medicine Index gives insight into what the pharmaceutical industry is doing to improve access to medicine across the world. It independently ranks and evaluates the world's largest pharmaceutical companies on their policies and practices for improving access to medicine in developing countries and has been published every two years since 2008. 

20 companies were analysed by the 2014 Index which together accounts for more than 50% of the global pharmaceutical market.

More detailed information is available here: http://www.accesstomedicineindex.org/ranking

Methodology

The framework is constructed along seven areas of focus, which cover the range of company business activities that experts consider most relevant to access to medicine. Within each area, the Index assesses four aspects of company action: commitment, transparency, performance and innovation. In 2014 there were 95 indicators.

The Index is a relative ranking, where companies are compared with each other rather than against an absolute. The highest attainable scores for each indicator do not reflect an ideal characteristic of industry behaviour, but a culmination of stakeholder views of what can be reasonably expected of companies. Additionally, companies do not receive negative scores in indicators, meaning they can never score below zero.

More detailed methodology is available here: http://www.accesstomedicineindex.org/methodology-0

Bulk Import